BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1748422)

  • 1. [Immunodiagnosis of ovarian cancer].
    Zhang J; Cao Z; Sun Z; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor associated antigen in ovarian carcinoma.
    Negishi Y; Mutai Y; Akiya K; Fujiwara Y; Singh G
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):126-32. PubMed ID: 6199439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated antigen for cystadenocarcinomas of the ovary.
    Bhattacharya M; Barlow JJ
    Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
    Chow SN; Chiang WT; Wei PY
    Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTA.
    Pant KD; Zamora PO; Rhodes BA; Sachatello CR; Hagihara PF; Griffen WO; van Nagell JR; Fulks R; Ram MD
    Tumour Biol; 1984; 5(5):243-54. PubMed ID: 6442455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterophile antigens in serous cystadenocarcinoma of the human ovary.
    Kamada M; Mori T; Sakamoto Y; Daitoh T; Furumoto H; Irahara M; Aono T; Mori T
    Asia Oceania J Obstet Gynaecol; 1992 Dec; 18(4):387-95. PubMed ID: 1283511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
    Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
    Kobayashi H; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.